Recently, the weibsite Cancernetwork (https://www.cancernetwork.com), run by MJH Life ScienceTM, which is the largest private medical media company in the United States, highlighted our recent publication on nanomedicine for the treatment of HER2 breast cancer (Angewandte Chemie International Edition, 2019, 10.1002/anie.201904860) in a paper entitled “Nanomedicine Approach Could Offer New Way to Target HER2+ Breast Cancer”.